PREPRINT (not peer reviewed)

Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: PsyArXiv
Date: 2021-05-19
Source: PsyArXiv
DOI: 10.31234/osf.io/q3ymd
PubMed: Unavailable

Authors

Lewis-Healey E Laukkonen RE van Elk M.

Watch author

Derived topics and classifications

psilocybin Depression Mechanism of Action Clinical Trial Drug Interactions Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06